A study to evaluate the safety of Rosuvastatin in Children and Adolescents with Homozygous Familial Hypercholesterolemia

Trial Identifier: D356NC00001
Sponsor: AstraZeneca
NCTID:: NCT02434497
Start Date: June 2015
Primary Completion Date: November 2016
Study Completion Date: November 2016
Condition: Hypercholesterolemia

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
Belgium Brussels (Woluwé-St-Lambert), Belgium, 1200
Canada, QC Chicoutimi, QC, Canada, G7H 7K9
Denmark Copenhagen, Denmark, DK-2100
Israel Halfa, Israel, 31096
Malaysia Kubang Kerian, Malaysia, 16150
Taiwan Taipei City, Taiwan, 11217